This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Apr;116(4):849-850.

doi: 10.14309/ajg.0000000000001068.

Response to Ma and Wu

Jeffrey Mather¹

Affiliations

PMID: 33982974
DOI: 10.14309/ajg.0000000000001068

Comment

Response to Ma and Wu

Jeffrey Mather. Am J Gastroenterol. 2021 Apr.

. 2021 Apr;116(4):849-850.

doi: 10.14309/ajg.0000000000001068.

Author

Jeffrey Mather¹

Affiliation

¹ 1Hartford Hospital, West Hartford, Connecticut, USA.

PMID: 33982974
DOI: 10.14309/ajg.0000000000001068

No abstract available

PubMed Disclaimer

Comment on

Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19.
Mather JF, Seip RL, McKay RG. Mather JF, et al. Am J Gastroenterol. 2020 Oct;115(10):1617-1623. doi: 10.14309/ajg.0000000000000832. Am J Gastroenterol. 2020. PMID: 32852338 Free PMC article.
Association Between Famotidine Use and Clinical Outcomes in Patients With COVID-19: Assessment of Available Evidence.
Ma T, Wu M. Ma T, et al. Am J Gastroenterol. 2021 Apr;116(4):848-849. doi: 10.14309/ajg.0000000000001008. Am J Gastroenterol. 2021. PMID: 33982973 Free PMC article. No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information